Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This trial is conducted in Europe. The aim of this trial is to test if there is bioequivalence between the insulin aspart 100 U/mL (U100) formulation and the new insulin aspart 200 U/mL (U200) formulation.
Epistemonikos ID: d412b2448158fd233098d9ba10dbbda0a64ad9b1
First added on: May 10, 2024